Close Menu

NEW YORK (GenomeWeb) – DiaSorin Molecular said today that the US Food and Drug Administration has cleared the company's Simplexa VZV Direct assay for detecting varicella-zoster virus.

The assay is for use with cerebrospinal fluid samples and can help in diagnosing meningitis and encephalitis. It requires 50 microliters of CSF per test and can be used with DiaSorin Molecular's Liaison MDx instrument. It also complements the Cypress, California-based firm's Simplexa HSV 1 and 2 Direct assay, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.